Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.
GYENNO SCIENCE CO., LTD, Shenzhen, 518000, People's Republic of China.
J Neuroeng Rehabil. 2024 Sep 18;21(1):163. doi: 10.1186/s12984-024-01452-4.
The acute levodopa challenge test (ALCT) is a universal method for evaluating levodopa response (LR). Assessment of Movement Disorder Society's Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS III) is a key step in ALCT, which is some extent subjective and inconvenience.
This study developed a machine learning method based on instrumented Timed Up and Go (iTUG) test to evaluate the patients' response to levodopa and compared it with classic ALCT. Forty-two patients with parkinsonism were recruited and administered with levodopa. MDS-UPDRS III and the iTUG were conducted in both OFF-and ON-medication state. Kinematic parameters, signal time and frequency domain features were extracted from sensor data. Two XGBoost models, levodopa response regression (LRR) model and motor symptom evaluation (MSE) model, were trained to predict the levodopa response (LR) of the patients using leave-one-subject-out cross-validation.
The LR predicted by the LRR model agreed with that calculated by the classic ALCT (ICC = 0.95). When the LRR model was used to detect patients with a positive LR, the positive predictive value was 0.94.
Machine learning based on wearable sensor data and the iTUG test may be effective and comprehensive for evaluating LR and predicting the benefit of dopaminergic therapy.
急性左旋多巴挑战测试(ALCT)是评估左旋多巴反应(LR)的通用方法。运动障碍协会统一帕金森病评定量表第三部分(MDS-UPDRS III)的评估是 ALCT 的关键步骤,在某种程度上具有主观性和不便性。
本研究开发了一种基于仪器化计时起立行走(iTUG)测试的机器学习方法,用于评估患者对左旋多巴的反应,并将其与经典 ALCT 进行比较。招募了 42 名帕金森病患者,并给予左旋多巴治疗。在停药和服药状态下,均进行 MDS-UPDRS III 和 iTUG 测试。从传感器数据中提取运动学参数、信号时间和频域特征。使用留一受试者交叉验证,训练两个 XGBoost 模型,即左旋多巴反应回归(LRR)模型和运动症状评估(MSE)模型,以预测患者的 LR。
LRR 模型预测的 LR 与经典 ALCT 计算的 LR 一致(ICC=0.95)。当使用 LRR 模型来检测具有阳性 LR 的患者时,阳性预测值为 0.94。
基于可穿戴传感器数据和 iTUG 测试的机器学习可能是评估 LR 和预测多巴胺能治疗获益的有效且全面的方法。